Self-reported community sources commonly describe starting at very low doses (10-25% of the typical maintenance dose) and slowly titrating upward to reduce this
Researching Glutathione beyond the basics
Published in JAMA Neurology, the study highlights the potential of GLP-1 RA therapy as an alternative approach to managing this challenging neurological condition
Individuals with a Focus On Preventive Health Even if you do not have type 2 diabetes or other specific health conditions, you may still benefit from exploring GLP-1 shots from BodyLogicMD if you are interested in preventive health
In both patient populations with pre-existing cardiovascular disease, DPP-4 inhibitors are recommended as one possible third-line therapy besides SGLT-2 inhibitors, thiazolidinediones, or insulin, when therapeutic goals are not met with the previous dual combination
A qualified doctor can create a personalized synergistic plan and dosing schedule to ensure safety and achieve maximum results